Navigation Links
Cynosure to Announce Second-Quarter 2008 Financial Results on July 29
Date:7/15/2008

WESTFORD, Mass., July 15 /PRNewswire-FirstCall/ -- Cynosure, Inc. (Nasdaq: CYNO), a leading developer and manufacturer of a broad array of light-based aesthetic treatment systems, today announced that the company will host its second-quarter 2008 conference call on Tuesday, July 29, 2008 at 9:00 a.m. ET.

On the call, President and Chief Executive Officer Michael Davin and Executive Vice President and Chief Financial Officer Timothy Baker will discuss Cynosure's second-quarter financial results, as well as the company's business outlook and growth strategy.

Those who wish to listen to the conference call webcast should visit the "Investor Relations" section of the company's website at http://www.cynosure.com. The live call also can be accessed by dialing (877) 407-5790 or (201) 689-8328. If you are unable to listen to the live call, the webcast will be archived on the company's website.

About Cynosure, Inc.

Cynosure, Inc. develops and markets aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular lesions, rejuvenate skin through the treatment of shallow vascular and pigmented lesions, laser lipolysis and temporarily reduce the appearance of cellulite. Cynosure's products include a broad range of laser and other light-based energy sources, including Alexandrite, pulsed dye, Nd:YAG and diode lasers, as well as intense pulsed light. Cynosure was founded in 1991.

For corporate or product information, contact Cynosure at 800-886-2966, or visit http://www.cynosure.com.

Contact

Scott Solomon

Vice President

Sharon Merrill Associates, Inc.

617-542-5300

cyno@investorrelations.com


'/>"/>
SOURCE Cynosure, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Cynosure President and CEO Michael Davin Named Ernst & Young Entrepreneur of the Year(R) 2008 Award Winner in New England
2. Cynosure Expands Presence in China with the Opening of Sales Office in Beijing
3. Cynosure to Present at 2008 Citi Investment Research Global Health Care Conference
4. Cynosures Accolade(TM) Workstation for Pigmented Lesions Receives Korean Regulatory Approval
5. Cynosure to Announce First-Quarter 2008 Financial Results on April 29
6. Cynosure Launches Three Aesthetic Products at American Academy of Dermatology 2008 Annual Meeting
7. CoolTouch Inc. Responds to Cynosure Patent Infringement Lawsuit
8. Cynosure Files Patent Infringement Lawsuit Against CoolTouch Inc.
9. Cynosure to Announce Third-Quarter 2007 Financial Results on November 1
10. Cynosure to Present at the Maxim Group Growth Conference
11. Retirement Living TV Announces Series Premiere of Viewpoint with Lea Thompson on July 18, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... April 29, 2016 , ... The number of chronically ... aging – meaning that there is an urgent need for highly skilled care managers ... solution, delivering a multi-pronged approach to train and retain care managers, and enhance their ...
(Date:4/28/2016)... ... ... offering a special deal on its webstore. , Buy 1 product and get ANYTHING (including ... with lesser value. In addition, a free bonus of 3 top serums in a ... many women (men, too) love our products and get good results. We want to introduce ...
(Date:4/28/2016)... Oaks, CA (PRWEB) , ... April 28, 2016 , ... ... is currently number one in Central America and is looking to grow their market ... marketing for such an exceptional brand as La Sirena Foods and indirectly ...
(Date:4/28/2016)... ... April 28, 2016 , ... The ... a new CDISC standard, Clinical Trial Registry (CTR) XML. Clinical trial registries ... will make it possible to build applications that generate submissions for multiple, ...
(Date:4/28/2016)... West Palm Beach, FL (PRWEB) , ... April 28, 2016 , ... ... time for the spring season. Smart pots are frequently used by professional organic farmers ... time for growers to order their supply of fabric pots. Our goal is to ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... 2016 , Net Sales of $1.90 billion ... the prior year period, and an increase of 1.2% on ... EPS for the first quarter were $0.52 reported, a decrease ... an increase of 29.9% over the prior year period ... guidance for 2016 Zimmer Biomet Holdings, Inc. (NYSE ...
(Date:4/28/2016)... 2016  ValGenesis, Inc., the market leader ... today announced that a prominent world provider ... chronic kidney failure has selected ValGenesis Validation ... validation process. The global medical device manufacturer ... manage their validation processes electronically. Upon completion ...
(Date:4/27/2016)... BASEL , Schweiz, April 27, 2016 ... des Sachs CEO Forums in Zürich ... Phase-II-Studie ihres führenden Wirkstoffkandidaten STR001 zur Erhaltung ... (CI) eingesetzt wurde, bekannt. Für die umfassende ... Deutschland und Frankreich angeworben. STR001 wird während ...
Breaking Medicine Technology: